These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20473525)

  • 21. A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population.
    Aytekin T; Aytekin A; Maralcan G; Gokalp MA; Ozen D; Borazan E; Yilmaz L
    Asian Pac J Cancer Prev; 2014; 15(17):7181-5. PubMed ID: 25227811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between CCND1 G870A polymorphism and radiotherapy response in high-risk human papillomavirus-related cervical cancer].
    Liang S; Zhang N; Huang R; Jiang J; Chen L; Lu Z; Li S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 40(11):1205-9. PubMed ID: 26643423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity.
    El Menshawy N; El Marghany AB; Sarhan MM; Aladle DA
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2941-2947. PubMed ID: 33112552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
    Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
    Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.
    Cui J; Shen L; Wang Y
    Asian Pac J Cancer Prev; 2012; 13(10):5023-5. PubMed ID: 23244103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
    Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
    Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients.
    Pandey A; Bahl C; Sharma S; Singh N; Behera D
    Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.
    Warchoł T; Kruszyna L; Lianeri M; Roszak A; Jagodziński PP
    Pathol Oncol Res; 2011 Mar; 17(1):133-7. PubMed ID: 20680537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
    In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
    Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
    Sergentanis TN; Economopoulos KP
    Mol Biol Rep; 2011 Nov; 38(8):4955-63. PubMed ID: 21161398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
    Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
    Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
    Li J; Luo F; Zhang H; Li L; Xu Y
    Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and
    Salimi S; Shahrakipour M; Hajizadeh A; Mokhtari M; Mousavi M; Teimoori B; Yaghmaei M
    Biomed Rep; 2017 Feb; 6(2):237-241. PubMed ID: 28357079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
    Wang S; Huang Y; Su R; Fang Z; Han M
    Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
    Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
    Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis.
    Wen L; Hu YY; Yang GL; Liu DX
    Biomed Rep; 2014 Jul; 2(4):549-554. PubMed ID: 24944806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.